Diagnosis and treatment of multiple endocrine neoplasia type 1 (MEN1)

Minerva Endocrinologica

Volumn 38, Issue 1, 2013, Pages 17-28

  Gaztambide, S ^a   Vazquez, F ^a   Castano L ^a  

^a HOSPITAL DE CRUCES   (Spain)

Author keywords

Genetic testing; Hyperparathyroidism; Multiple endocrine neoplasia type 1; Neuroendocrine tumors; Pituitary neoplasms

Indexed keywords

ANTINEOPLASTIC AGENT; BROMOCRIPTINE; CABERGOLINE; CALCIUM; CINACALCET; HISTAMINE H2 RECEPTOR ANTAGONIST; INTERFERON; PARATHYROID HORMONE; PEGVISOMANT; PROTON PUMP INHIBITOR; SOMATOSTATIN DERIVATIVE; VITAMIN D;

ADRENAL CORTEX TUMOR; ARTIFICIAL EMBOLISM; CANCER COMBINATION CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CARCINOID; COMPUTER ASSISTED TOMOGRAPHY; CYTOREDUCTIVE SURGERY; ENDOSCOPIC ECHOGRAPHY; GASTRINOMA; GLUCAGONOMA; HEMANGIOFIBROMA; HUMAN; HYPERCALCEMIA; HYPERGASTRINEMIA; HYPOCALCEMIA; HYPOPHYSIS ADENOMA; INSULINOMA; LIPOMA; MENINGIOMA; MULTIPLE ENDOCRINE NEOPLASIA; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREAS RESECTION; PANCREATIC NEUROENDOCRINE TUMOR; PARATHYROID ADENOMA; PARATHYROID CARCINOMA; PARATHYROID HORMONE BLOOD LEVEL; PARATHYROIDECTOMY; PRIMARY HYPERPARATHYROIDISM; PROPHYLAXIS; REVIEW; THYMECTOMY; THYROID TUMOR; UNSPECIFIED SIDE EFFECT; VIPOMA; ZOLLINGER ELLISON SYNDROME;

BIOLOGICAL MARKERS; EARLY DIAGNOSIS; EXONS; GENOTYPE; HUMANS; MULTIPLE ENDOCRINE NEOPLASIA TYPE 1; MUTATION; PANCREATIC NEOPLASMS; PARATHYROID NEOPLASMS; PHENOTYPE; PITUITARY NEOPLASMS; PREVALENCE; PROGNOSIS; PROTO-ONCOGENE PROTEINS; SPAIN;

EID: 84876546096     PISSN: 03911977     EISSN: 18271634     Source Type: Journal    
DOI: None     Document Type: Review

References (80)

1. Wermer P. Genetic aspects of adenomatosis of endocrine glands. Am J Med 1954;16:363-71.
2. Thakker RV. Multiple endocrine neoplasia type 1 (MEN1). In: Robertson RP, Thakker RV, editors. Translational endocrinology and metabolism. Vol 2. Chevy Chase, MD: The Endocrine Society; 2011. p. 13-44.
3. Chandrasekharappa SC, Guru SC, Manickam P, Olufemi SE, Collins FS, Emmert-Buck MR. Positional cloning of the gene for multiple endocrine neoplasia type 1. Science 1997;276:404-7.
4. Yang Y, Hua X. In search of tumor suppressing functions of menin. Mol Cell Endocrinol 2007;265-266:34-41.
5. Scacheri PC, Davis S, Odom DT, Crawford GE, Perkins S, Halawi MJ et al. Genome-wide analysis of menin binding provides insights into MEN1 tumorigenesis. PLoS Genet 2006;2:e51.
6. Brandi ML, Gagel RF, Angeli A, Bilezikian JP, BeckPeccoz P, Bordi C et al. Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab 2001;86:5658-71. (Pubitemid 33152604)
7. th edition. Philadelphia, PA: Elsevier; 2010. p. 2719-41.
8. Lemos MC, Thakker RV. Multiple endocrine neoplasia type 1 (MEN1): analysis of 1336 mutations reported in the first decade following identification of the gene. Hum Mutat 2008;29:22-32.
9. Flanagan DE, Armitage M, Clein GP, Thakker RV. Prolactinoma presenting in identical twins with multiple endocrine neoplasia type 1. Clin Endocrinol 1996;45:117-20. (Pubitemid 26248941)
10. Concolino P, Rossodivita A, Carrozza C, Raffaelli M, Lombardi CP, Rigante D et al. A novel MEN 1 frameshift germline mutation in two Italian monozygotic twins. Clin Chem Lab Med 2008;46:824-6. (Pubitemid 351821640)
11. Doherty GM, Olson JA, Frisella MM, Lairmore TC, Wells SA Jr, Norton JA. Lethality of multiple endocrine neoplasia type 1. World J Surg 1998;22.581-6.
12. Dean PG, van Heerden JA, Farley DR, Thompson GB, Grant CS, Harmsen WS et al. Are patients with multiple endocrine neoplasia type I prone to premature death? World J Surg 2000;2:1437-41.
13. Geerdink EA, Van der Luijt RB, Lips CJ. Do patients with multiple endocrine neoplasia syndrome type 1 benefit from periodical screening? Eur J Endocrinol 2003;149:577-82. (Pubitemid 38054703)
14. Goudet P, Murat A, Binquet C, Cardot-Batiters C, Costa A, Ruszniewski P et al. Risk factors and causes of death in MEN1 disease. A GTE (Groupe d'Etude des Tumeurs Endocrines) cohort study among 758 patients. World J Surgery 2010;34:249-55.
15. Machens A, Schaaf L, Karges W, Frank-Raue K, Bartsch DK, Rothmund M et al. Age-related penetrance of endocrine tumours in multiple endocrine neoplasia type 1 (MEN1): a multicentre study of 258 gene carriers. Clin Endocrinol 2007;67:613-22. (Pubitemid 47416322)
16. Lourenço DM Jr, Coutinho FL, Toledo RA, Gonçalves TD, Montenegro FL, Toledo SP. Biochemical, bone and renal patterns in hyperparthyroidism associated with multiple endocrine neoplasia type 1. Clinics (Sao Paulo) 2012;67(Suppl 1):99-108.
17. Coutinho FL, Lourenco DM Jr, Toledo RA, Montenegro FL, Toledo SP. Post-surgical follow-up of primary hyperparathyroidism associated with multiple endocrine neoplasia type 1. Clinics (Sao Paulo) 2012;67(Suppl 1):169-72.
18. Pieterman CR, van Hulsteijn LT, den Heijer M, van der Luijt RB, Bonenkamp JJ, Hermus AR et al. Primary hyperparathyroidism in MEN1 patients: a cohort study with longterm follow-up on preferred surgical procedure and the relation with genotype. Study Group. Ann Surg 2012;255:1171-8.
19. Tonelli F, Marcucci T, Giudici F, Falchetti A, Brandi ML. Surgical approach in hereditary hyperparathyroidism. Endocr J 2009;56:827-41.
20. Schreinemakers JM, Pieterman CR, Scholten A, Vriens MR, Valk GD, Rinkes IH. The optimal surgical treatment for primary hyperparathyroidism in MEN1 patients: a systematic review. World J Surg 2011;35:1993-2005.
21. Filopanti M, Verga U, Ermetici F, Olgiati L, Eller-Vainicher C, Corbetta S et al. MEN1-related hyperparathyroidism: response to cinacalcet and its relationship with the calcium-sensing receptor gene variant Arg990Gly. Eur J Endocrinol 2012;167:157-64.
22. Del Pozo C, García-Pascual L, Balsells M, Barahona MJ, Veloso E, González C et al. Parathyroid carcinoma in multiple endocrine neoplasia type 1. Case report and review of the literature. Hormones 2011;10:326-31.
23. Thakkar RV, Newey PJ, Walls GV, Bilezikian J, Dralle H, Ebeling DR et al. Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1). J Clin Endocrinol Metab 2012;97:2990-3011.
24. Akerström G, Hessman O, Hellman P, Skogseid B. Pancreatic tumours as part of the MEN-1 syndrome. Best Pract Res Clin Gastroenterol 2005;19:819-30. (Pubitemid 41614126)
25. Chanson P, Cadiot G, Murat A. Management of patients and subjects at risk for multiple endocrine neoplasia type 1: MEN 1. GENEM 1. Groupe d'Etude des Néoplasies Endocriniennes Multiples de type 1. Horm Res 1997;47:211-20. (Pubitemid 27196455)
26. Marx S, Spiegel AM, Skarulis MC, Doppman JL, Collins FS, Liotta LA. Multiple endocrine neoplasia type 1: clinical and genetic topics. Ann Intern Med 1998;129:484-94. (Pubitemid 28428085)
27. Gibril F, Schumann M, Pace A, Jensen RT. Multiple endocrine neoplasia type 1 and Zollinger-Ellison syndrome: a prospective study of 107 cases and comparison with 1009 cases from the literature. Medicine 2004;83:43-83. (Pubitemid 38124855)
28. Anlauf M, Garbrecht N, Henopp T, Schmitt A, Schienger R, Raffel A et al. Sporadic versus hereditary gastrinomas of the duodenum and pancreas: distinct clinico-pathological and epidemiological features. World J Gastroenterol 2006;12:5440-6. (Pubitemid 44501800)
29. Fendrich, V, Langer, P, Waldmann, J, Bartsch, DK, Rothmund M. Management of sporadic and multiple endocrine neoplasia type 1 gastrinomas. Br J Surg 2007;94:1331-41. (Pubitemid 350144380)
30. Jensen RT, Berna MJ, Bingham DB, Norton JA. Inherited pancreatic endocrine tumor syndromes: Advances in molecular pathogenesis, diagnosis, management, and controversies. Cancer 2008;113:1807-43.
31. Tonelli F, Fratini G, Nesi G, Tommasi MS, Batignani G, Falchetti A et al. Pancreatectomy in multiple endocrine neoplasia type 1-related gastrinomas and pancreatic endocrine neoplasias. Ann Surg 2006;244:61-70. (Pubitemid 44297449)
32. Imamura M, Komoto I, Ota S, Hiratsuka T, Kosugi S, Doi R et al. Biochemically curative surgery for gastrinoma in multiple endocrine neoplasia type 1 patients. World J Gastroenterol 2011;17:1343-53.
33. Turner JJ, Wren AM, Jackson JE, Thakker RV, Meeran K. Localization of gastrinomas by selective intra-arterial calcium injection. Clin Endocrinol 2002;57:821-5. (Pubitemid 36963010)
34. Scarsbrook AF, Thakker RV, Wass JA, Gleeson FV, Phillips RR. Multiple endocrine neoplasia: spectrum of radiologic appearances and discussion of a multitechnique imaging approach. Radiographics 2006;26:433-51. (Pubitemid 43515316)
35. Cadiot G, Vuagnat A, Doukhan I, Murat A, Bonnaud G, Delemer B et al. Prognostic factors in patients with Zollinger-Ellison syndrome and multiple endocrine neoplasia type 1. Groupe d'Etude des Néoplasies Endocriniennes Multiples (GENEM and groupe de Recherche et d'Etude du Syndrome de Zollinger-Ellison (GRESZE). Gastroenterology 1999;116:286-93.
36. Norton JA. Surgical treatment and prognosis of gastrinoma. Best Pract Res Clin Gastroenterol 2005; 19:799-805. (Pubitemid 41614124)
37. Norton JA, Fraker DL, Alexander HR, Venzon DJ, Doppman JL, Serrano J et al. Surgery to cure the Zollinger-Ellison syndrome. N Engl J Med 1999;341:635-44. (Pubitemid 29399042)
38. Lopez CL, Falconi M, Waldmann J, Boninsegna L, Fendrich V, Goretzki PK et al. Partial Pancreaticoduodenectomy Can Provide Cure for Duodenal Gastrinoma Associated With Multiple Endocrine Neoplasia Type 1. Ann Surg 2012;00:1-7.
39. Fabbri HC, Mello MP, Soardi FC, Esquiaveto-Aun AM, Oliveira DM, Denardi FC et al. Long-term follow-up of an 8-year-old boy with insulinoma as the first manifestation of a familial form of multiple endocrine neoplasia type 1. Arq Bras Endocrinol Metabol 2010;54:754-60.
40. Giudici F, Nesi G, Brandi ML, Tonelli F. Surgical management of insulinomas in multiple endocrine neoplasia type 1. Pancreas 2012;41:547-53-
41. Carneiro DM, Levi JU, Irvin GL 3rd. Rapid insulin assay for intraoperative confirmation of complete resection of insulinomas. Surgery 2002; 132.937-42.
42. Newey PJ, Jeyabalan J, Walls GV, Christie PT, Gleeson FV, Gould S et al. Asymptomatic children with multiple endocrine neoplasia type 1 mutations may harbor nonfunctioning pancreatic neuroendocrine tumors. J Clin Endocrinol Metab 2009;94:3640-6.
43. Thomas-Marques L, Murat A, Delemer B, Penfomis A, Cardot-Bauters C, Baudin E et al. Prospective endoscopic ultrasonographic evaluation of the frequency of nonfunctioning pancreaticoduodenal endocrine tumors in patients with multiple endocrine neoplasia type 1. Am J Gastroenterol 2006;101:266-73. (Pubitemid 43381666)
44. Goudet P, Murat A, Binquet C, Cardot-Bauters C, Costa A, Ruszniewski P et al. Risk factors and causes of death in MEN1 disease. A GTE (Groupe d'Etude des Tumeurs Endocrines) cohort study among 758 patients. World J Surg 2010;34:249-55.
45. Triponez F, Dosseh D, Goudet P, Cougard P, Bauters C, Murat A et al. Epidemiology data on 108 MEN 1 patients from the GTE with isolated nonfunctioning tumors of the pancreas. Ann Surg 2006;243:265-72. (Pubitemid 43185447)
46. Triponez F, Goudet P, Dosseh D, Cougard P, Bauters C, Murat A et al. Is surgery beneficial for MEN1 patients with small (≤2 cm), nonfunctioning pancreaticoduodenal endocrine tumor? An analysis of 65 patients from the GTE. World J Surg 2006;30:654-62. (Pubitemid 43724090)
47. Raymond E, Dahan L, Raoul JL, Bang YJ, Borbath I, Lombard-Bohas C et al. Sunitinib malate for the treatment of pancreatic neuroendocrine tumors. N Engl J Med 2011;364:501-13.
48. Yao JC, Shah MH, Ito T, Bohas CL, Wolin EM, Van Cutsem E et al. Everolimus for advanced pancreatic neuroendocrine tumors. N Engl J Med 2011;364:514-23.
49. Trump D, Farren B, Wooding C, Pang JT, Besser GM, Buchanan KD et al. Clinical studies of multiple endocrine neoplasia type 1 (MEN1). QJM 1996;89:653-69. (Pubitemid 26319017)
50. Vergès B, Boureille F, Goudet P, Murat A, Beckers A, Sassolas G et al. Pituitary disease in MEN type 1 (MEN1): data from the France-Belgium MEN1 multicenter study. J Clin Endocrinol Metab 2002;87:457-65. (Pubitemid 34158204)
51. Trouillas J, Labat-Moleur F, Sturm N, Kujas M, Hey mann MF, Figarella-Branger D et al. Pituitary tumors and hyperplasia in multiple endocrine neoplasia type 1 syndrome (MEN1): a case-control study in a series of 77 patients versus 2509 non-MEN1 patients. Am J Surg Pathol 2008;32:534-43. (Pubitemid 351458295)
52. Lourenço DM Jr, Toledo RA, Mackowiak II, Coutinho FL, Cavalcanti MG, Correia-Deur JE et al. Multiple endocrine neoplasia type 1 in Brazil: MEN1 founding mutation, clinical features, and bone mineral density profile. Eur J Endocrinol 2008;159:259-74.
53. Olufemi SE, Green JS, Manickam P, Guru SC, Agarwal SK, Rester MB et al. Common ancestral mutation in the MEN1 gene is likely responsible for the prolactinoma variant of MEN1 (MEN1Burin) in four kindreds from Newfoundland. Hum Mutat 1998;11:264-9. (Pubitemid 28177866)
54. Scheithauer BW, Laws ER Jr, Kovacs K, Horvath E, Randall RV, Carney JA. Pituitary adenomas of the multiple endocrine neoplasia type I syndrome. Semin Diagn Pathol 1987;4:205-11.
55. Stratakis CA, Schussheim DH, Freedman SM, Keil MF, Pack SD, Agarwal SK et al. Pituitary macroadenoma in a 5-year-old: an early expression of multiple endocrine neoplasia type 1. J Clin Endocrinol Metab 2000;85:4776-80. (Pubitemid 32157665)
56. Beckers A, Betea D, Valdes Socin H, Stevenaert A. The treatment of sporadic versus MEN1-related pituitary adenomas. J Intern Med 2003;253:599-605. (Pubitemid 36649091)
57. Goudet P, Bonithon-Kopp C, Murat A, Ruszniewski P, Niccoli P, Ménégaux F et al. Gender-related differences in MEN1 lesion occurrence and diagnosis: a cohort study of 734 cases from the Groupe d'etude des Tumeurs Endocrines. Eur J Endocrinol 2011;165:97-105.
58. Sakurai A, Suzuki S, Kosugi S, Okamoto T, Uchino S, Miya A et al. Multiple endocrine neoplasia type 1 in Japan: establishment and analysis of a multicentre database. Clin Endocrinol 2012;76:533-9.
59. Goudet P, Murat A, Cardot-Bauters C, Emy P, Baudin E, du Boullay Choplin H et al. Thymic neuroendocrine tumors in multiple endocrine neoplasia type 1: a comparative study on 21 cases among a series of 761 MEN1 from the GTE (Groupe des Tumeurs Endocrines). World J Surg 2009;33:1197-207.
60. Gal AA, Kornstein MJ, Cohen C, Duarte IG, Miller JI, Mansour KA. Neuroendocrine tumors of the thymus: a clinicopathological and prognostic study. Ann Thorac Surg 2001;72:1179-82. (Pubitemid 32938001)
61. Berna MJ, Annibale B, Marignani M, Luong TV, Corleto V, Pace A et al. A prospective study of gastric carcinoids and enterochromaffin-like cell changes in multiple endocrine neoplasia type 1 and Zollinger-EUison syndrome: identification of risk factors. J Clin Endocrinol Metab 2008;93:1582-91. (Pubitemid 351656492)
62. Schaefer S, Shipotko M, Meyer S, Ivan D, Klose KJ, Waldmann J et al. Natural course of small adrenal lesions in multiple endocrine neoplasia type 1: an endoscopic ultrasound imaging study. Eur J Endocrinol 2008;158:699-704. (Pubitemid 351639608)
63. Gatta-Cherifi B, Chabre O, Murat A, Niccoli P, Cardot-Bauters C, Rohmer V et al. Adrenal involvement in MEN1. Analysis of 715 cases from the Groupe d'etude des Tumeurs Endocrines database. Eur J Endocrinol 2012;166:269-79.
64. Simonds WF, Varghese S, Marx SJ, Nieman LK. Cushing's syndrome in multiple endocrine neoplasia type 1. Clin Endocrinol 2012;76:379-86.
65. Vidal A, Iglesias MJ, Fernández B, Fonseca E, Cordido F. Cutaneous lesions associated to multiple endocrine neoplasia syndrome type 1. J Eur Acad Dermatol Venereol 2008;22:835-8. (Pubitemid 351837118)
66. Asgharian B, Chen YJ, Patronas NJ, Peghini PL, Reynolds JC, Vortmeyer A et al. Meningiomas may be a component tumor of multiple endocrine neoplasia type 1. Clin Cancer Res 2004;10:869-80.
67. van Wijk JP, Dreijerink KM, Pieterman CR, Lips CJ, Zelissen PM, Valk GD. Increased prevalence of impaired fasting glucose in MEN1 gene mutation carriers. Clin Endocrinol 2012;76.67-71.
68. Turner JJ, Christie PT, Pearce SH, Turnpenny PD, Thakker RV. Diagnostic challenges due to phenocopies: lessons from Multiple Endocrine Neoplasia typel (MEN1). Hum Mutat 2010;31:E1089-101.
69. Newey PJ, Thakker RV. Role of multiple endocrine neoplasia type 1 mutational analysis in clinical practice. Endocr Pract 2011;17(Suppl 3):8-17.
70. Scacheri PC, Davis S, Odom DT, Crawford GE, Perkins S, Halawi MJ et al. Genome-wide analysis of menin binding provides insights into MEN1 tumorigenesis. PLoS Genet 2006;2.e51.
71. Yang Y, Hua X. In search of tumor suppressing functions of menin. Mol Cell Endocrinol 2007;265-266:34-41. (Pubitemid 46273978)
72. Cavaco BM, Domingues R, Bacelar MC, Cardoso H, Barros L, Gomes L et al. Mutational analysis of Portuguese families with multiple endocrine neoplasia type 1 reveals large germline deletions. Clin Endocrinol 2002;56:465-73. (Pubitemid 34429621)
73. Hannan FM, Nesbit MA, Christie PT, Fratter C, Dudley NE, Sadler GP et al. Familial isolated primary hyperparathyroidism caused by mutations of the MEN1 gene. Nat Clin Pract Endocrinol Metab 2008,4:53-8. (Pubitemid 350291116)
74. Hao W, Skarulis MC, Simonds WF, Weinstein LS, Agarwal SK, Mateo C et al. Multiple endocrine neoplasia type 1 variant with frequent prolactinoma and rare gastrinoma. J Clin Endocrinol Metab 2004;89:3776-84. (Pubitemid 39071471)
75. Agarwal SK, Ozawa A, Mateo CM, Marx SJ. The MEN1 gene and pituitary tumours. Horm Res 2009;71(Suppl 2):131-8.
76. Burgess JR, Nord B, David R, Greenaway TM, Parameswaran V, Larsson C et al. Phenotype and phenocopy: the relationship between genotype and clinical phenotype in a single large family with multiple endocrine neoplasia type 1 (MEN 1). Clin Endocrinol 2000;53:205-11. (Pubitemid 30643455)
77. Belar O, De La Hoz C, Pérez-Nanclares G, Castaño L, Gaztambide S; Spanish MEN1 Group. Novel mutations in MEN1, CDKN1B and AIP genes in patients with multiple endocrine neoplasia type 1 syndrome in Spain. Clin Endocrinol 2012;76:719-24.
78. Langer P, Wild A, Hall A, Celik I, Rothmund M, Bartsch DK. Prevalence of multiple endocrine neoplasia type 1 in young patients with apparently sporadic primary hyperparathyroidism or pancreaticoduodenal endocrine tumours. Br J Surg 2003,90:1599-603. (Pubitemid 37533180)
79. Skandarajah A, Barlier A, Morlet-Barlat N, Sebag F, Enjalbert A, Conte-Devolx B et al. Should routine analysis of the MEN1 gene be performed in all patients with primary hyperparathyroidism under 40 years of age? World J Surg 2010;34:1294-8.
80. Berglund G, Lidén A, Hansson MG, Oberg K, Sjöden PO, Nordin K. Quality of life in patients with multiple endocrine neoplasia type 1 (MEN 1). Fam Cancer 2003;2:27-33. (Pubitemid 36534536)